2008-12-5

Shenzhen, China, December 5, 2008 – Edan Instruments, a leading medical device company in China, today announced the closing of Series A investments from Softbank China, WI Harper Group and Matrix Partners China.

“We are very pleased to have three top tier institutional investors join forces with us to make Edan Instruments a successful company in the global medical device industry.” Said Hao Zhang, Founder and Chairman of the Company. “This is the first and only institutional round that we did and with the new financing and expertise that the investors bring on board, Edan is best positioned to capture the tremendous potential of the current Chinese healthcare reform as well as penetrate global markets through leveraging our superior cost structure of R&D and manufacturing. ” he added.

"Edan is one of the few Chinese medical device companies that we saw who has the best-in-class management team with strong and forward-looking R&D orientation.” said Dr. Ping Hua, General Partner from Softbank China. “Given the long time relationship between the three investors and our common understanding of the healthcare sector in China, I believe that Edan will be a leader in China medical device industry.”, said Dr. David Wang, Healthcare Partner from WI Harper Group. “We are extremely impressed by the strategy thinking and solid management of the Company.” David Zhang, Managing Partner and Co-founder of Matrix Partners China commented.

About Edan Instruments, Inc.

Edan Instruments, Inc. is a leading medical equipment manufacturer in China. Located in Shenzhen, a major electronic center where talent and productivity converge, Edan is home to more than 500 employees working in R&D, manufacturing and marketing. We manufacture, develop, and market Fetal Monitors, Fetal Doppler, Electrocardiographs (ECG), Patient Monitors, Ultrasound and Transcranial Doppler (TCD). Edan implements both ISO-9001 and ISO-13485 quality standards throughout the designing, manufacturing, and servicing procedures.

Since its inception in 1995, Edan’s market share has been growing tremendously and today, Edan's CBS series TCD, M9 Patient Monitors, Fetal Monitors and Fetal Doppler are among the top choices for majority of the Chinese hospitals. Edan entered overseas market in 2002, and the export annual sales increased 100% p.a. since. Edan has 20 offices in China, and a solid distribution network in more than 100 countries all over the world, handling sales, marketing, and post-sales services in those regions. Today Edan is recognized for the excellent products and services it provides its customers worldwide. For more information, please visit www.edan.com.cn